Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVO.L Share News (AVO)

  • There is currently no data for AVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Investors Encouraged By Kingfisher CEO Change

Wed, 10th Sep 2014 11:06

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
Kingfisher, up 2.9%. The DIY retailer said the head of its Castorama business in France, Veronique Laury, will take over as group chief executive before the end of the current financial year, tasked with expanding the company's online sales, integrating recent acquisitions and expanding some of its brands into new markets. In a statement, the company said current CEO Ian Cheshire will step down by the end of the financial year in January. Cheshire told journalists that after seven years as CEO, and 17 years in the Kingfisher business, he has decided that he didn't want to remain in place through the next five-year strategic plan the company has started. The home improvement retailer's pretax profit for the 26 weeks to August 2 fell by 6.5% to GBP375 million, down from GBP401 million last year when profit was buoyed by a tax repayment related to its previous demerger of the Kesa business. Excluding exceptional items, pretax profit was flat on the year at GBP364 million, as a 0.9% rise in revenue to GBP5.77 billion, from GBP5.72 billion, was offset by a slight drop in operating margin.

Barratt Developments, up 1.4%. The housebuilder said it plans to return around GBP950 million to shareholders over the next three years, as it more than doubled its final dividend following a strong year underpinned by recovery in the UK housing market. The company, which will drop out of the FTSE 100 on September 22, said it will pay a final dividend of 7.1 pence for the year that ended June 30, compared with 2.5 pence the year before, making a total dividend of 10.3p. The company paid a total dividend of 2.5 pence a year earlier. Under a special cash payment programme, Barratt hopes to make a special cash payment alongside its full-year 2015 results of GBP100 million, followed by a special cash payment of GBP125 million alongside its full-year 2016 results and a special cash payment of GBP175 million with its full-year 2017 results. The capital return plan came as the housebuilder posted pretax of GBP390.6 million for the year to June 30, up from GBP192.0 million a year earlier, as revenue rose 21% to GBP3.16 billion from GBP2.60 billion.
-------
FTSE 100 LOSERS
-------
Admiral Group, down 4.6%, Hargreaves Lansdown, down 2% and G4S, down 1.3%. The companies are amongst the fallers in the blue-chip index after going ex-dividend, meaning new buyers no longer qualify for the latest dividend payouts.
-------
FTSE 250 WINNERS
-------
African Barrick Gold, up 4.6%. The East Africa-focused gold production company has had its rating increased by Goldman Sachs to Neutral, from Sell, with a price target increase to 230 pence from 210p. The stock currently trades at 240.3p.

Premier Oil, up 1.2%. The oil exploration and production company said that the subsea oil storage tank, jacket and topsides have been successfully installed at its Solan oil field and it will now start the offshore hook up and commissioning programme. In a statement, the company said the precise timing of first oil from the field will depend on the progress of the hook up and commissioning.
-------
FTSE 250 LOSERS
-------
Greene King, down 2.6%. The company said growth in its like-for-like sales in the first 18 weeks of the year was muted against tough comparatives from last year and a disappointing World Cup this year, though it expects further improvement in the rest of the year as momentum for its Pub Partners and Brewing & Brands businesses continues. It said like-for-like sales in its retail arm were up 0.4% in the first 18 weeks.

The Restaurant Group, down 2.2%, Berendsen, down 1.6%, Rathbone Brothers, down 1.6%, and Temple Bar Investment Trust, down 1.3%. The companies are amongst the fallers in the mid-chip index after going ex-dividend.
-------
AIM ALL-SHARE WINNERS
-------
Ncondezi Energy, up 16%. The company said that it has agreed a 25-year commercial deal with Electricidade de Mozambique on the sale of electricity from the Ncondezi Power Project. The deal includes the range for the starting electricity tariff to be paid by EdM, said Ncondezi, which will then be subject to adjustments throughout the 25-year operational life of the project. The agreement is subject to a number of conditions, including the introduction of a strategic investor acceptable to EdM, confirmation of the availability of political and commercial risk cover, bankable EPC contracts, and agreeing a timetable for the substantial completion of all key project agreements involving EdM, said Ncondezi.

Zytronic, up 16%. The company said it expects its pretax profit in the current financial year to be significantly above market expectations. Increased sales of larger touch products and the significant improvement in margins that it had reported when it released its interim results in May continued into the second half of the year and it said revenue is currently about 8% above the corresponding period of its last financial year.

Baron Oil, up 11%. The company said it has signed a farm-out agreement with Vale Oil and Gas, Peru, in a deal that means it now owns the entirety of Block XXI onshore northwest Peru. Vale, part of major Brazilian mining company Vale SA, has agreed to transfer its 70% working interest in Block XXI and make a payment of USD3.5 million to Baron Oil.

Sula Iron And Gold, up 11%. The exploration company said it has restarted work at the Ferensola project in Sierra Leone, targeting both iron ore and a new tantalum and niobium mineralisation target recently identified in the target area. Sula said geological interpretation and regional magnetic data at the site suggested potential for the banded iron formation to continue in a north easterly direction. The second target area is located north east of the known iron mineralisation area at the site and Sula said field crews completed grid surveying and line cutting in July in preparation for a magnetometer survey on the new target area.

Parity Group, up 7.6%. The information and marketing technology business said it swung to a profit in the first-half, after a number of years of losses as it relaunched one of its divisions. The company posted pretax profit of GBP120,000 for the six months ended June 30, compared with a GBP520,000 loss a year earlier, as revenue rose 3.8% at GBP48.3 million, from GBP46.5 million.

SolGold, up 7.5%. The company reported copper sulphide intersects, encouraging metallurgical tests, a second drill rig, and supportive induced-polarisation survey results at the Cascabel project in Ecuador. It said Hole 8 at the site had now reached a depth of 606.5 metres, with visible copper sulphide mineralisation starting at 378.2 metres. Preliminary metallurgical tests at the site showed 91-98% recovery of copper and gold. It added that the preliminary resistivity and conductance modelling from the IP survey supported the geological model for the site and the presence of porphyry targets.

Optimal Payments, up 6.7%. The online payments provider reported a jump in first-half pretax profit and said that robust trading since the end of that period means it now believes its full-year results will now come in ahead of its expectations. It made a USD27.5 million pretax profit in the six months ended June 30, compared with USD15.5 million in the corresponding period a year prior. Revenue increased by 34% to USD159.1 million, boosted by growth and improved gross margin at digital wallet business NETELLER. It also reported revenue at secure gateway and merchant account business NETBANX, with the company highlighting Asia as a particular area of growth.
-------
AIM ALL-SHARE LOSERS
-------
Frontier Resources International, off 25%. The oil and gas explorer reported a wider net loss for the first half of its financial year and said it was continuing to seek ways of raising fresh capital to fund its future exploration and development work. The company reported a net loss of USD681,000 for the six months to June 30, wider than the USD588,000 loss it reported a year earlier, as it booked USD239,000 in exchange differences on translation of foreign operations. The company doesn't make any revenue yet, so its loss depends on costs. It posted a pretax loss of USD442,000, narrowed from USD557,000 a year earlier, as administrative expenses and share payments rose, but not by as much as the USD185,000 expense it had booked for its AIM admission costs a year earlier.

Orogen Gold, down 22%. The gold explorer said it has raised GBP1.1 million after conditionally placing 1.02 billion new shares with existing and new investors, as it looks to advance the exploration programme at its Mutsk gold project in Armenia. The company said the shares were conditionally placed at 0.11 pence each and represented about 30% of its enlarged share capital.

Nature Group, down 15%. The maritime company said it swung to a pretax loss after contract delays hit its revenue, but was positive about its second half. Nature reported a pretax loss of GBP720,000 in the six months ended June 30, compared to a GBP1.4 million profit in the first six months of 2013, after it suffered from contract delays and its ongoing rebuild of its Gibraltar operation. Revenue fell to GBP9.1 million, from GBP11 million in the comparable period in 2013.

Advanced Oncotherapy, down 12%. The company said it has raised about GBP4.7 million before expenses through a placing and subscription of 145.6 million new shares, as it looks to fund the development of a new system for cancer treatments. It said it specifically wants to develop Linac for Image Guided Hadron Therapy (LIGHT) system. LIGHT is being developed along with ADAM, the spin-off from CERN acquired in 2012. The company said the new funds will be used to support the development of a complete LIGHT accelerator and will enable it to carry out the first installation of a LIGHT machine at SUNY Upstate Medical University in Syracuse, New York. In addition to the agreements to deliver the LIGHT system to hospitals such as the Upstate University hospital, Advanced Oncotherapy said it is in discussions with a number of other hospitals and healthcare organisations.
-------

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 21:30

IN BRIEF: Advanced Oncotherapy financing talks continue, funds delayed

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Provides update in relation to financing discussions and financial position. Says talks on the proposed financing have continued to make good progress. However, notes there have been further delays and the initial tranche of funding, which is still expected to be around USD15 million, has not yet been received. Hopes this will be received by the end of May but stresses there is no guarantee. Continues to expect the financing to require a restructuring of financial liabilities with a view to providing a long-term financing solution for the company to continue as a going concern. Warns that without additional funding the company is unlikely to be able to continue to trade and would very likely become insolvent and be placed into administration.

Read more
2 Apr 2024 17:35

TRADING UPDATES: Sareum ups retail offer; SThree nabs former ITV exec

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Feb 2024 18:52

EARNINGS AND TRADING: Frontier IP sells last of Exscientia holding

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
2 Feb 2024 14:06

IN BRIEF: Advanced Oncotherapy eyes USD15 million tranche in February

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Regarding its recapitalisation plan, company works alongside investor towards initial tranche of funding, which it expects to be about USD15 million to be received this month. However, it adds that there can be no guarantee that this funding will be received, nor that it will be received on time. Further, Advanced Oncotherapy says it remains in advanced talks with a third-party investor regarding a short-term loan facility which would provide the company with additional short term bridge financing.

Read more
9 Jan 2024 14:06

IN BRIEF: Advanced Oncotherapy in advanced talks regarding loan

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Continues to work on its recapitalisation plan with an unnamed third party investor. Says discussions are at an advanced stage but has not entered into any binding agreements with the investor, nor received any funds. This comes after it signed a non-binding term sheet with the investor in October. The investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing. The firm currently owes GBP28 million to trade and other unsecured creditors and GBP41 million of financial debt.

Read more
23 Oct 2023 18:51

IN BRIEF: Advanced Oncotherapy in talks over possible cash injection

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - Updates on financing discussions and current financial position. Signs non-binding term sheet with a third-party investor. Investor is expected to provide funding of up to USD80 million to meet the company's cashflow requirements through to the European certification of the LIGHT System. Notes the treatment of first patients with LIGHT is now targeted for 2024 with certification of the LIGHT System to follow thereafter. Anticipates the financing to be a mixture of equity and debt financing.

Read more
3 Oct 2023 18:29

IN BRIEF: Advanced Oncotherapy results delayed, funding talks continue

Advanced Oncotherapy PLC - London-based provider of proton therapy for cancer treatment - On Friday, says it is not in a position to publish its accounts for the year ended December 31, 2022, and the unaudited interim results for the six months ended June 30, together with the 2022 annual report. Explains the 2023 interim results are contingent on the finalisation and publication of the 2022 annual report.

Read more
17 Jul 2023 21:41

Advanced Oncotherapy plans to raise up to GBP110 million

(Alliance News) - Advanced Oncotherapy PLC on Monday announced a prospective recapitalisation and funding plan to raise up to GBP110 million.

Read more
30 Jun 2023 19:54

TRADING UPDATES: Jadestone Energy holds production and capex targets

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Friday and not separately reported by Alliance News:

Read more
2 Jun 2023 19:37

IN BRIEF: Advanced Oncotherapy optimistic of securing further funding

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment company - Announces it has received a conversion notice for a portion of the convertible notes, which were issued to a French counterparty, as announced March 1 into new shares in the company. Says 10 convertible notes have been converted worth GBP50,000 at a conversion price of GBP0.25. Company also pays GBP56,702 conversion fee as the conversion price is below the nominal value of the shares. States this will be settled through the issuance of 756,020 new shares. Further, says in talks to raise further funding under the secured loan note agreement as well as through other non-dilutive financing options and is hopeful of securing additional financing during June 2023. Optimistic of a satisfactory outcome on the financing options being explored. In addition, company says it has issued convertible notes totalling GBP34,600 under its secured convertible loan note agreement.

Read more
15 May 2023 21:10

TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Apr 2023 10:38

Advanced Oncotherapy considers US sale of business to secure funding

(Alliance News) - Advanced Oncotherapy PLC on Tuesday said it is continuing to consider funding options to allow it to complete its first Light machine and begin treating patients later this year.

Read more
20 Mar 2023 13:06

IN BRIEF: Advanced Oncotherapy receives GBP1.2 million in funds

Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about GBP1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes GBP500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, GBP5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing.

Read more
1 Mar 2023 21:15

TRADING UPDATES: Galantas to raise GBP1.2 million in private placement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
18 Jan 2023 21:58

TRADING UPDATES: Bankers net assets drop; Invinity Energy wins funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.